Role of LTB4in the pathogenesis of elastase-induced murine pulmonary emphysema

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 299, Issue 6, 2010, Pages

  Shim, Y Michael ^a   Paige, Mikell ^b   Hanna, Halim ^a   Kim, Su H ^a   Burdick, Marie D ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Leukotriene B4; Neutrophil

Indexed keywords

ELASTASE; LEUKOTRIENE B4; EPOXIDE HYDROLASE; LEUKOTRIENE A4 HYDROLASE; PANCREATIC ELASTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS; LUNG COMPLIANCE; LUNG EMPHYSEMA; LUNG VOLUME; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; WILD TYPE; AGED; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; GENETICS; LUNG; MALE; METABOLISM; MIDDLE AGED; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY;

AGED; ANIMALS; EPOXIDE HYDROLASES; FEMALE; HUMANS; LEUKOTRIENE B4; LUNG; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; NEUTROPHILS; PANCREATIC ELASTASE; PULMONARY EMPHYSEMA;

EID: 78649833530     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00116.2010     Document Type: Article

References (51)

1. Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, Das R, Jett M, Mulshine JL. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 15: 2007-2009, 2001.
2. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez A, Mulshine JL. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97: 806-813, 1996. (Pubitemid 26057100)
3. Bailie MB, Standiford TJ, Laichalk LL, Coffey MJ, Strieter R, Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 157: 5221-5224, 1996.
4. Beeh KM, Kornmann O, Buhl R, Culpitt SV, Giembycz MA, Barnes PJ. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest 123: 1240-1247, 2003.
5. Busse W. The role and contribution of leukotrienes in asthma. Ann Allergy Asthma Immunol 81: 17-26; quiz 26-19, 1998.
6. Byrum RS, Goulet JL, Snouwaert JN, Griffiths RJ, Koller BH. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J Immunol 163: 6810-6819, 1999.
7. Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B. Leukotrienes are potent constrictors of human bronchi. Nature 288: 484-486, 1980. (Pubitemid 11163960)
8. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 83: 64-70, 2008.
9. De Vooght V, Vanoirbeek JA, Haenen S, Verbeken E, Nemery B, Hoet PH. Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma. Toxicology 259: 84-89, 2009.
10. DiGiovanni FA, Ellis R, Wattie J, Hirota JA, Southam DS, Inman MD. Concurrent dual allergen exposure and its effects on airway hyperresponsiveness, inflammation and remodeling in mice. Dis Model Mech 2: 275-282, 2009.
11. Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M. CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 111: 1032-1040, 2003.
12. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286: 264-265, 1980.
13. Fretland DJ, Widomski DL, Anglin CP, Penning TD, Yu S, Djuric SW. Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146. Inflammation 17: 353-360, 1993.
14. Friedrich EB, Tager AM, Liu E, Pettersson A, Owman C, Munn L, Luster AD, Gerszten RE. Mechanisms of leukotriene B4-triggered monocyte adhesion. Arterioscler Thromb Vasc Biol 23: 1761-1767, 2003.
15. Goetzl EJ, Pickett WC. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med 153: 482-487, 1981.
16. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. Plos Med 1: e8, 2004.
17. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 160: 1968-1975, 1999.
18. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653, 2004.
19. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 88: 891-897, 1991.
20. Ishizawa K, Kubo H, Yamada M, Kobayashi S, Numasaki M, Ueda S, Suzuki T, Sasaki H. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 556: 249-252, 2004.
21. Izquierdo JL, Almonacid C, Parra T, Perez J. [Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease]. Arch Bronconeumol 42: 332-337, 2006.
22. Janelle MF, Doucet A, Bouchard D, Bourbonnais Y, Tremblay GM. Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema. Biol Chem 387: 903-909, 2006. (Pubitemid 44100237)
23. Jonasson S, Hedenstierna G, Hedenstrom H, Hjoberg J. Comparisons of effects of intravenous and inhaled methacholine on airway physiology in a murine asthma model. Respir Physiol Neurobiol 165: 229-236, 2009.
24. Jonasson S, Hjoberg J, Hedenstierna G, Basu S. Allergen-induced formation of F2-isoprostanes in a murine asthma model identifies oxidative stress in acute airway inflammation in vivo. Prostaglandins Leukot Essent Fatty Acids 80: 1-7, 2009.
25. Kostikas K, Gaga M, Papatheodorou G, Karamanis T, Orphanidou D, Loukides S. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest 127: 1553-1559, 2005.
26. Malmsten CL, Palmblad J, Uden AM, Radmark O, Engstedt L, Samuelsson B. Leukotriene B4: a highly potent and stereospecific factor stimulating migration of polymorphonuclear leukocytes. Acta Physiol Scand 110: 449-451, 1980.
27. March TH, Cossey PY, Esparza DC, Dix KJ, McDonald JD, Bowen LE. Inhalation administration of all-trans-retinoic acid for treatment of elastase-induced pulmonary emphysema in Fischer 344 rats. Exp Lung Res 30: 383-404, 2004.
28. Martin EL, Sheikh TA, Leco KJ, Lewis JF, Veldhuizen RA. Contribution of alveolar macrophages to the response of the TIMP-3 null lung during a septic insult. Am J Physiol Lung Cell Mol Physiol 293: L779-L789, 2007.
29. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 84: 1609-1619, 1989.
30. Mikell Paige MSS, Dorothy Bunyan A, Shim YM. HPLC quantification of 5-hydroxyeicosatetraenoic acid in human lung cancer tissues. Biomed Chromatogr 23: 817-821, 2009.
31. Mulgrew AT, Taggart CC, McElvaney NG. Alpha-1-antitrypsin deficiency: current concepts. Lung 185: 191-201, 2007.
32. Nakano R, Oka M, Nakamura T, Fukuda M, Kawabata S, Terashi K, Tsukamoto K, Noguchi Y, Soda H, Kohno S. A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein. Biochem Biophys Res Commun 251: 307-312, 1998.
33. O'Byrne PM, Postma DS. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease. Asthma Research Group. Am J Respir Crit Care Med 159: S41-S63, 1999.
34. Palmblad J, Malmsten CL, Uden AM, Radmark O, Engstedt L, Samuelsson B. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 58: 658-661, 1981.
35. Park SJ, Wiekowski MT, Lira SA, Mehrad B. Neutrophils regulate airway responses in a model of fungal allergic airways disease. J Immunol 176: 2538-2545, 2006.
36. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 46: 798-825, 2001.
37. Pillow JJ, Korfhagen TR, Ikegami M, Sly PD. Overexpression of TGF-alpha increases lung tissue hysteresivity in transgenic mice. J Appl Physiol 91: 2730-2734, 2001. (Pubitemid 33108039)
38. Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, Calcagni P, Mapp CE, Ciaccia A, Fabbri LM. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 150: 1646-1652, 1994.
39. Sharma R, Singhal SS, Wickramarachchi D, Awasthi YC, Awasthi S. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance. Int J Cancer 112: 934-942, 2004.
40. Shim YM, Zhu Z, Zheng T, Lee CG, Homer RJ, Ma B, Elias JA. Role of 5-lipoxygenase in IL-13-induced pulmonary inflammation and remodeling. J Immunol 177: 1918-1924, 2006.
41. Teckman JH, Lindblad D. Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management. Curr Gastroenterol Rep 8: 14-20, 2006.
42. Turino GM. The origins of a concept: the protease-antiprotease imbalance hypothesis. Chest 122: 1058-1060, 2002.
43. Wardlaw AJ, Hay H, Cromwell O, Collins JV, Kay AB. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 84: 19-26, 1989.
44. Weibel ER. Principles and methods for the morphometric study of the lung and other organs. Lab Invest 12: 131-155, 1963.
45. Weibel ER, Hsia CC, Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 102: 459-467, 2007.
46. Wenzel SE, Larsen GL, Johnston K, Voelkel NF, Westcott JY. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis 142: 112-119, 1990. (Pubitemid 20224588)
47. Woolhouse IS, Bayley DL, Stockley RA. Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax 57: 709-714, 2002.
48. Wozel G, Blasum C, Winter C, Gerlach B. Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: results of a pilot study. Inflamm Res 46: 420-422, 1997.
49. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 106: 1081-1093, 2000.
50. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788, 1999.
51. Zhu Z, Ma B, Zheng T, Homer RJ, Lee CG, Charo IF, Noble P, Elias JA. IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol 168: 2953-2962, 2002.